A series of Mann-Whitney U tests were conducted to determine whether there is a difference in IgG and IgA levels between pARD who were receiving methotrexate (MTX) or TNF-α inhibitors at the time of infection, vaccination, or the second event (Subgroup 3) and those who were not. This evidence concerns the gene TNF and infection.